CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 919.8% in July

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the target of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 1,019,814 shares, a growth of 919.8% from the June 30th total of 100,000 shares. Based on an average daily volume of 37,832,732 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of OTCMKTS CBDL remained flat at $0.00 during trading hours on Friday. The company had a trading volume of 3,289,047 shares, compared to its average volume of 16,329,163. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.

CBD Life Sciences Company Profile

CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.